Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04622163 · ClinicalTrials.gov registry record · NA

Secondary Mentoring Program Evaluation

A NA study of Satisfaction, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT04622163: Completed NA study of Satisfaction, sponsored by Massachusetts General Hospital.

NCT04622163 is a NA study of Satisfaction that has completed, run by Massachusetts General Hospital. The registered enrollment target is 40 participants, below the 129-participant average among 6 other Satisfaction trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04622163, a NA study of Satisfaction, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Mentorship is essential to job satisfaction and promotion among academic physicians, and literature suggests that a single mentor is rarely sufficient. The investigators are studying whether implementation of a secondary mentorship program among physicians at their institution leads to improved job satisfaction over 6 months.

Primary Outcome

Job satisfaction is measured by the following question on a questionnaire developed by the investigators: "Overall how satisfied are you with your current position?" Responses are on a 5-point Likert scale (very unsatisfied, unsatisfied, neither, satisfied, very satisfied).

Conditions Studied

Interventions

  • OTHER Secondary Mentor
  • OTHER Career Development Resources

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-01-04
Est. Completion 2022-02-03
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT04622163 record still lists

NCT04622163 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 129-participant average among 6 other Satisfaction trials with a reported enrollment target (69% lower).

The record links to 1 condition, with Satisfaction appearing as the primary indexed condition, and to 2 interventions - of which Secondary Mentor is the first listed.

NCT04622163 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04622163 about?

NCT04622163 is a clinical study titled "Secondary Mentoring Program Evaluation". Mentorship is essential to job satisfaction and promotion among academic physicians, and literature suggests that a single mentor is rarely sufficient. The investigators are studying whether implementation of a secondary mentorship program among physicians at their institution leads to improved job ...

What is the current status of trial NCT04622163?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-01-04. Estimated completion is 2022-02-03.

What conditions does trial NCT04622163 study?

This clinical trial studies the following conditions: Satisfaction.

What interventions are being tested in trial NCT04622163?

The interventions under investigation include: Secondary Mentor (OTHER), Career Development Resources (OTHER).

Who is sponsoring clinical trial NCT04622163?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04622163 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Satisfaction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04622163, the US trial registry maintained by the National Library of Medicine. NCT04622163 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.